Genome stability relies on proper coordination of mitosis and cytokinesis, where dynamic microtubules capture and faithfully segregate chromosomes into daughter cells. With a high-content RNAi imaging screen targeting more than 2,000 human lncRNAs, we identify numerous lncRNAs involved in key steps of cell division such as chromosome segregation, mitotic duration and cytokinesis. Here, we provide evidence that the chromatin-associated lncRNA, linc00899, leads to robust mitotic delay upon its depletion in multiple cell types. We perform transcriptome analysis of linc00899-depleted cells and identify the neuronal microtubule-binding protein, TPPP/p25, as a target of linc00899. We further show that linc00899 binds TPPP/p25 and suppresses its transcription. In cells depleted of linc00899, upregulation of TPPP/p25 alters microtubule dynamics and delays mitosis. Overall, our comprehensive screen uncovers several lncRNAs involved in genome stability and reveals a lncRNA that controls microtubule behaviour with functional implications beyond cell division.
Long noncoding RNAs (lncRNAs) are defined as RNAs longer than 200 nucleotides that lack functional open reading frames, and represent a major transcriptional output of the mammalian genome1,2. LncRNAs control numerous cellular processes including the cell cycle, differentiation, proliferation and apoptosis3,4,5 and their deregulation is associated with human disease including cancer6,7. Several lncRNAs regulate the levels of key cell cycle regulators such as cyclins, cyclin-dependent kinases (CDK), CDK inhibitors and p538,9. LncRNAs are also linked to cell division as they can regulate the levels of mitotic proteins10,11 or by modulating the activity of enzymes involved in DNA replication and cohesion12. In addition, lncRNAs can control chromosome segregation by controlling kinetochore formation via centromeric transcription13 or by acting as decoys for RNA-binding proteins involved in maintaining genome stability14,15. All of these lncRNA-dependent functions can occur through transcriptional and posttranscriptional gene regulation, chromatin organisation and/or posttranslational regulation of protein activity5. These mechanisms usually involve lncRNAs establishing interactions with proteins and/or nucleic acids, which allows lncRNA-containing complexes to be recruited to specific RNA or DNA targets16. Although lncRNAs represent >25% of all human genes (GENCODE v24), the biological significance of the majority of lncRNAs remains unknown.
Systematic screens in human cells identify protein-coding genes involved in cell survival, cell cycle progression and chromosome segregation17,18,19,20. Similar loss-of function screens are performed to identify lncRNAs with cell cycle functions. For example, CRISPR interference (CRISPRi) is used in high-throughput screens to identify lncRNA loci important for cell survival21 and revealed lncRNAs whose functions were highly cell-type specific. Similar results are obtained in a CRISPR/Cas9 screen targeting lncRNA splice sites22. In a recent RNA interference (RNAi) screen targeting human cancer-relevant lncRNAs, Nötzold and colleagues used time-lapse microscopy imaging of HeLa Kyoto cells and identify 26 lncRNAs linked to cell cycle regulation and cell morphology23. However, this screen only studied ~600 lncRNAs in the genome with respect to a limited number of phenotypes.
With an aim to identify lncRNAs with functions in cell division, we perform a more comprehensive high-content imaging RNAi screen involving the depletion of 2231 lncRNAs in HeLa cells. We develop image analysis pipelines to quantify a diverse set of mitotic features in fixed cells, and discover multiple lncRNAs with roles in mitotic progression, chromosome segregation, and cytokinesis. We focus on linc00899, a hitherto uncharacterised lncRNA that regulates mitotic progression by repressing the transcription of the microtubule-stabilising protein TPPP/p25. Our study demonstrates the regulatory function of linc00899 in mitotic microtubule behaviour and provides a comprehensive imaging data resource for further investigation of the roles of lncRNAs in cell division.
High-content RNAi screen identifies lncRNAs in cell division
To identify lncRNAs involved in regulating cell division, we performed two consecutive RNAi screens (screen A and B). Briefly, we transfected HeLa cells with the human Lincode small interfering RNA (siRNA) library targeting 2231 lncRNAs (Fig. 1a; Supplementary Data 1) and examined their effects using high-content screening of mitotic phenotypes. Each lncRNA was targeted with a SMARTpool of four different siRNAs. Following 48-h incubation, cells were fixed and processed for immunostaining and subsequent automated image acquisition and analysis. In screen A, antibodies targeting CEP215 (to label centrosomes), α-tubulin (to label the microtubule cytoskeleton), phalloidin (to label the actin cytoskeleton) and Hoechst (to label nuclei) were used. In screen B (Fig. 1b–d), phospho-histone H3 (PHH3; to specifically label mitotic cells), α-tubulin, γ-tubulin (to label centrosomes) and Hoechst was used. We used these two screens as independent approaches to robustly identify lncRNAs with functions in mitotic progression, chromosome segregation and cytokinesis.
In each screen, we employed automated image analysis to segment the cells and developed in-house pipelines to quantify defects in each of abovementioned categories upon lncRNA depletion (Supplementary Fig. 1a). First, for defects in mitotic progression, we determined the percentage of mitotic cells (also called mitotic index), because an increase in the mitotic index implies a delay or block in mitotic progression. We performed nuclear segmentation and computed the mitotic index (Supplementary Fig. 1b) where mitotic cells were identified by the presence of mitotic spindle staining (detected by α-tubulin and CEP215) in screen A or by positive PHH3 staining of chromosomes in screen B. Second, for quantification of chromosome segregation defects, a category that includes chromatin bridges and lagging chromatids, we identified anaphase cells based on α-tubulin staining between the separating nuclei, in addition to Hoechst (DNA) signal (Supplementary Fig. 1c). Third, to evaluate defects in the execution of cytokinesis, we segmented the cytoplasm of interphase cells and scored the number of cells with cytokinetic bridges based on α-tubulin staining (Supplementary Fig. 1d).
For each category, we ascertained lncRNAs for which depletion increased the frequency of defects relative to the mean across all lncRNAs in the siRNA library. Negative control siRNA and cells without any siRNA treatment were used as controls, for which we observed no systematic differences in the frequencies of each phenotype (Fig. 1b–d). We identified candidate lncRNAs involved in mitotic progression (Fig. 1a; linc00899 and C1QTNF1-AS1), chromosome segregation (Fig. 1b; PP7080 and linc00883) and cytokinesis (Fig. 1c; linc00840 and loc729970). As a positive control for mitotic progression defects, we used a SMARTpool against the protein-coding gene Ch-TOG/CKAP5, whose depletion leads to mitotic delay and increased mitotic index24 (Fig. 1b). For chromosome segregation, we successfully identified the lncRNA NORAD (Fig. 1c), depletion of which increases the rate of chromosome segregation errors14,15. Supplementary Data 2 contains raw data and computed Z-scores for each lncRNA and phenotype.
To confirm our findings, we conducted a validation screen targeting the top 25 lncRNA candidates identified in the initial screens for mitotic progression and cytokinesis (Supplementary Data 3). Depletion of each lncRNA was performed in two biological (and in total eight technical) replicates. For mitotic progression, this screen corroborated the increase in mitotic index following depletion of linc00899 and C1QTNF1-AS1 (Supplementary Fig. 2a). Although loc100289019-depleted cells also displayed an elevated mitotic index, levels of the lncRNA did not change upon RNAi25. For the cytokinesis category, we observed an increase in the number of cells with cytokinetic bridges after linc00840 depletion and a decrease after loc729970 depletion, but neither led to multinucleation (Supplementary Fig. 2b, c). Furthermore, elevated mitotic index and cytokinesis defects were not associated with reduced cell viability for these lncRNAs (Supplementary Fig. 2d). As positive controls, we used Ch-TOG and ECT2 (a key regulator of cytokinesis)26, the depletion of which led to expected phenotypes: an increased number of mitotic and multinucleated cells, respectively (Supplementary Fig. 2a–c).
Mitotic perturbations caused by depletion of the lncRNA candidates were further characterised by time-lapse microscopy imaging to investigate the dynamics of each phenotype. As expected, a marked mitotic delay was observed in HeLa cells depleted of linc00899 and C1QTNF1-AS1, lncRNAs associated with increased mitotic index (Supplementary Fig. 3). Next, we depleted linc00883 and PP7080, lncRNAs with potential functions in chromosome segregation (Supplementary Fig. 4). Using time-lapse microscopy imaging of HeLa Kyoto cells stably expressing histone H2B-mCherry (a chromatin marker) and eGFP-α-tubulin (a microtubule marker)18, we found that depletion of linc00883 and PP7080 increased the rate of chromosome segregation errors to a similar extent as that of NORAD. We then depleted linc00840 and loc729970 (Supplementary Fig. 5), lncRNAs from the cytokinesis category, and found that knockdown of linc00840 doubled the time required for cells to cleave the cytokinetic bridge, whereas knockdown of loc729970 resulted in shorter cytokinesis. Overall, our screen identified functions of lncRNAs in the control of cell division, supporting the idea that lncRNAs play an important role in cell cycle progression.
Molecular characterisation of linc00899 and C1QTNF1-AS1
Two lncRNAs associated with delayed mitotic progression, linc00899 and C1QTNF1-AS1, were selected for in-depth functional analysis. Linc00899 and C1QTNF1-AS1 are spliced and polyadenylated lncRNAs. Linc00899 (also known as loc100271722 or ENSG00000231711) is a multi-exonic intergenic lncRNA located on chromosome 22 and is ~1.6 kb long. C1QTNF1-AS1 (also known as ENSG00000265096) is an lncRNA on chromosome 17 that is ~1 kb long and is antisense to a protein-coding gene “C1q And TNF Related 1” (C1QTNF1/CTRP1). Both lncRNAs are annotated in GENCODE, show signs of active transcription (Fig. 2a) and have low protein-coding potential (Supplementary Fig. 6a). Although we did not identify a syntenic ortholog for linc00899 in the mouse genome, short stretches of conserved regions27 are present within exon 1 (Supplementary Fig. 6b). This places linc00899 in a group of lncRNAs with conserved exonic sequences embedded in a rapidly evolving transcript architecture28. Based on the syntenic position of protein-coding gene C1QTNF1, we found a mouse ortholog for C1QTNF1-AS1 (GM11747, ENSMUG000000086514) that is also antisense to the mouse C1qtnf1. Thus C1QTNF1-AS1 is an lncRNA that is conserved across mouse and human, while linc00899 contains short conserved stretches at its 5′ end representing possible functional domains29,30.
We then validated the expression of both lncRNAs in HeLa cells using a variety of techniques. cDNA generated from polyadenylated RNA was used for rapid amplification of cDNA ends (RACE) to define the locations of the 5′ cap and 3′ end identifying several isoforms for linc00899 and C1QTNF1-AS1 (Supplementary Fig. 6c). The diversity of isoforms for both lncRNAs is consistent with a previous study on lncRNA annotation27. Expression data from ENCODE cell lines indicated that linc00899 and C1QTNF1-AS1 were present in both the nucleus and cytoplasm of HeLa-S3 cells (Fig. 2b), which we further confirmed by RNA fluorescence in situ hybridisation (RNA FISH) (Fig. 2c). Quantitative real-time polymerase chain reaction (qPCR) analyses on RNA extracted from different cellular fractions revealed that linc00899 but not C1QTNF1-AS1 is associated with chromatin (Fig. 2d). Although some linc00899 foci remain detectable in mitotic cells (Supplementary Fig. 6d), they do not associate with mitotic chromatin, arguing against a mitotic bookmarking role for these lncRNAs. linc00899 and C1QTNF1-AS1 are estimated to occur, on average, in five and two copies per cell, respectively, and do not show cell cycle dependency in their expression (Supplementary Fig. 6e, f). In the Genotype-Tissue Expression (GTEx) RNA-seq dataset31 from human tissue, C1QTNF1-AS1 was highly expressed in the adrenal gland and spleen, while linc00899 was broadly expressed in most of the tissues, with uterus being the highest (Supplementary Fig. 6g).
Linc0889 and C1QTNF1-AS1 facilitate timely mitotic progression
To characterise the mitotic phenotype further, we depleted linc00899 and C1QTNF1-AS1 in HeLa and HeLa Kyoto cells and examined the effect on mitotic progression with immunofluorescence and time-lapse microscopy imaging, respectively. Quantification of lncRNA-depleted cells using RNAi revealed an increase in the mitotic index compared to cells treated with control siRNA (Fig. 3a, b). This was confirmed by time-lapse microscopy imaging of HeLa Kyoto cells where depletion of linc00899 and C1QTNF1-AS1 resulted in increased mitotic duration (Supplementary Fig. 7a–c). We found that cells treated with control siRNA initiated anaphase onset at 40 ± 10 min (median ± SD), whereas the cells depleted of linc00899 and C1QTNF1-AS1 initiate anaphase onset at 100 ± 173 and 240 ± 146 min, respectively (Fig. 3c). Although unaligned chromosomes near spindle poles were detectable in a small population of linc00899-depleted cells (and these showed delays of >4 h), in the majority of cells bipolar spindle formation and chromosome congression occurred with normal kinetics, and cells exhibited a delay in the metaphase to anaphase transition (Fig. 3d upper panels and Supplementary Movies 1 and 2). By contrast, nearly all C1QTNF1-AS1-depleted cells showed an impairment of chromosome congression to the metaphase plate (Fig. 3d lower panels and Supplementary Movie 3).
We next asked whether these phenotypes could be recapitulated by a loss-of-function (LOF) method other than RNAi. We used locked nucleic acid (LNA) oligonucleotides as a complementary method to target lncRNA expression due to their higher efficiency in depleting nuclear compared to cytoplasmic lncRNAs32,33. We successfully depleted both linc00899 and C1QTNF1-AS1 with two different LNAs and selected the LNA with more efficient depletion (denoted LNA1) for subsequent studies (Fig. 3e). Similar to RNAi, we observed an increase in the mitotic index following LNA1-mediated depletion of linc00899 and C1QTNF1-AS1 (Fig. 3f) and confirmed the mitotic delay with time-lapse microscopy imaging of HeLa Kyoto cells (Fig. 3g, h; Supplementary Fig. 7d–f and Supplementary Movies 4–6). The apparent increase in α-tubulin intensity at the spindle poles of C1QTNF1-AS1-depleted cells is most likely due to spindles being short and multipolar. Together, these data indicate that linc00899 and C1QTNF1-AS1 have biological functions in regulation of mitotic progression, albeit through different mechanisms.
To further confirm the phenotype of C1QTNF1-AS1 depletion, we inserted a polyadenylation poly(A) signal (pAS)34 downstream of the C1QTNF1-AS1 transcriptional start site (TSS) using CRISPR-Cas9 gene editing. This method allows lncRNAs to be transcribed but terminates them prematurely due to the inserted pAS, preventing the expression of full-length lncRNA transcripts. We obtained four homozygous clones for C1QTNF1-AS1 with similar knockdown efficiency, all of which displayed mitotic delay similar to RNAi- and LNA-mediated depletion of C1QTNF1-AS1 (Supplementary Fig. 8). These results suggest that the C1QTNF1-AS1 transcript, and not transcription at the C1QTNF1-AS1 locus, is required for the regulation of mitotic progression. Similar experiments for linc00899 were hindered by the presence of over four copies of linc00899 in the HeLa genome (https://cansar.icr.ac.uk/cansar/cell-lines/HELA/copy_number_variation/) preventing the generation of homozygous clones despite the use of two different guide RNAs (gRNAs) targeting different regions of linc00899.
Linc0889-dependent regulation of TPPP in mitotic progression
To reveal transcriptional regulatory functions of linc00899 and C1QTNF1-AS1, we performed RNA sequencing (RNA-seq) of cells following RNAi- and LNA-mediated depletion of each lncRNA. We selected the subset of differentially expressed genes (DEGs) that changed in a consistent direction with both LOF methods to minimise any potential method specific off-target effects as shown previously25. For C1QTNF1-AS1, a single DEG was detected, which was C1QTNF1-AS1 itself (Fig. 4a). These data argue against a transcriptional role for C1QTNF1-AS1 and suggest that its function in mitotic progression could depend on C1QTNF1-AS1 protein interactors.
For linc00899, we identified eight DEGs in common across the two LOF methods (Fig. 4a), of which four were changing in the same direction with both methods (Fig. 4b). Since we were not able to validate changes in RAI14, DNAAF5 and ITGB1BP1 expression at the mRNA and protein levels (Supplementary Fig. 9), we decided to focus on TPPP/p25.
TPPP/p25 is a tubulin polymerisation-promoting protein with established roles in microtubule dynamics and mitosis35,36. TPPP was upregulated upon RNAi- and LNA-mediated depletion of linc00899 (Fig. 4c, d), which we validated at the protein level in asynchronous (Fig. 4e, f) as well as in mitotic cells (Supplementary Fig. 10a).
To address whether the mitotic delay in linc00899-depleted cells is due to increased TPPP levels, we performed single and double knockdowns of linc00899 and TPPP and analysed the mitotic progression (Fig. 4g). Whereas TPPP knockdown alone did not affect mitotic timing, depletion of linc00899 alone in HeLa cells led to a mitotic delay, consistent with results from HeLa Kyoto cells (Fig. 3c, g). However, cells with simultaneous depletion of linc00899 and TPPP progressed through mitosis with near-normal timing, a phenotype observed with both LOF methods. We confirmed that co-depletion of linc00899 and TPPP rescued the previously observed upregulation of the latter with qPCR (Fig. 4h, i). Similar results were obtained with an additional LNA oligonucleotide targeting the first intron of linc00899 (Supplementary Fig. 10b, c). These data suggest that linc00899 needs to be depleted at least by 50% to attain TPPP upregulation and mitotic delay in HeLa cells (Supplementary Fig. 10d, e).
Linc00889 controls microtubule dynamics in the spindle
TPPP is known to localise to the mitotic spindle, and its overexpression influences microtubule dynamics and stability in mammalian cells35,36,37,38. Overexpression of TPPP increases tubulin acetylation and also microtubule stability via microtubule bundling36. Thus we tested whether depletion of linc00899, which leads to upregulation of TPPP, had a similar effect. Immunofluorescence of linc00899-depleted cells using antibodies against α-tubulin (a microtubule marker) and acetylated α-tubulin (a marker of long-lived microtubules)39 showed a marked increase in acetylated α-tubulin levels (Fig. 5a), consistent with linc00899-depleted cells containing more long-lived microtubules. We next benchmarked the effects of linc00899 depletion on microtubules to those exerted by paclitaxel (taxol), a microtubule-stabilising agent that suppresses microtubule dynamics at nanomolar doses40,41. Cells were treated with 0.5–3 nM taxol, concentrations that suppress microtubule dynamics without affecting spindle morphology42 because high doses of taxol (5 nM–1 µM) block microtubule depolymerisation leading to highly aberrant mitotic spindles and cell death40. We analysed cells after 1- or 20-h taxol treatment. We found that the impact of linc008999 depletion on acetylated α-tubulin levels was comparable to that of 3 nM taxol (Fig. 5b, c), suggestive of impaired microtubule dynamics in linc008999-depleted cells.
As TPPP influences the growth velocity of microtubules by affecting their stability36, we examined the localisation of EB1 protein, which specifically associates with growing microtubule plus-ends where it regulates microtubule dynamics43. As expected, EB1 staining was apparent at the spindle pole and throughout the spindle in control cells but it was much reduced in intensity upon linc00899 depletion (Fig. 5d). Importantly, reduced EB1 signal was not due to diminished microtubule levels, because α-tubulin staining of the mitotic spindle was comparable between linc00899-depleted and control cells. Quantification of EB1 signal in mitotic cells confirmed the decrease in EB1 levels, indicating that linc00899 depletion lessens the number of growing microtubule ends, a phenotype consistent with a reduction in microtubule dynamics (Fig. 5e). Taken together, these data demonstrate that, by controlling TPPP expression levels, linc00899 limits the number of long-lived microtubules and maintains normal microtubule dynamics in mitotic HeLa cells.
To gain insight into why depletion of linc00899 and C1QTNF1-AS1 causes a mitotic delay, we examined the distribution of the kinetochore (CREST) and spindle (α-tubulin) markers in HeLa cells depleted of these lncRNAs (Fig. 6a). In contrast to controls, where most chromosomes were present in a narrow or wide metaphase plate, ~20% of linc00899-depleted mitotic cells displayed narrow metaphase plates with single unattached kinetochore pairs near the poles (congression defect I; Fig. 6a and Supplementary Fig. 11). Congression defects appeared even more severe in C1QTNF1-AS1-depleted cells, which showed very wide metaphase plates with several clusters of chromosomes surrounding both spindle poles (congression defect II; Fig. 6a and Supplementary Fig. 11). Phenotypes were confirmed with LNA-mediated depletion for both lncRNAs. The differences in mitotic phenotypes suggest that the mechanisms through which these two lncRNAs control mitotic progression are likely to be different.
Spindle assembly checkpoint (SAC) signalling at the kinetochores ensures that each and every chromosome is bi-oriented on the metaphase plate before anaphase is initiated44. To assess the status of SAC, we immunostained control and linc00899-depleted cells for the presence of Mad2, an essential component of the SAC signalling machinery45,46 (Fig. 6b). Frequency of Mad2 on narrow metaphase plates appeared slightly reduced in linc00899-depleted cells when compared to controls (12% vs 20%). However, this may not be of biological significance because 89% of linc00899-depleted cells with narrow metaphase plates exhibited Mad2 signal on the sister kinetochores of these uncongressed chromosomes. Thus active SAC due to uncongressed chromosomes contributes to the mitotic delay in linc00899-depleted cells.
Once chromosome bi-orient, they come under tension from pulling forces generated by kinetochore microtubules. Given the central role of microtubule dynamics in this process, and its impairment in linc00899-depleted cells, we determined the interkinetochore distances (inter-KT) of chromosomes, which are known to report of the tension that kinetochore pairs are subjected to (Fig. 6c, d)47. Whereas in cells treated with negative control siRNA or control LNA, the mean inter-KT distance was 1.4 ± 0.2 µm, bi-oriented chromosomes in linc00899-depleted cells had a reduced mean inter-KT distance of 1.2 ± 0.2 µm (Fig. 6e). Thus depletion of linc00899 leads to an overall decrease in tension across sister kinetochores.
In summary, we have demonstrated that linc00899 depletion suppresses microtubule dynamics, causes a chromosome congression defect and reduces tension on the metaphase plate. These defects are expected to preclude timely inactivation of the SAC, thus delaying anaphase onset.
Linc00899 regulates TPPP and mitosis in multiple cell lines
We next asked whether linc00899-mediated regulation of TPPP occurs in cell lines other than HeLa. RNAi-mediated depletion of linc00899 resulted in upregulation of TPPP in three normal diploid cell lines (hTERT-RPE1, retinal pigment epithelial cells; MCF10A, untransformed breast epithelial cells; HUVEC, primary human umbilical vein endothelial cells) where mitosis is ~25 min (Fig. 7a, c, e). Elevated TPPP levels were accompanied with a mitotic delay from ~8 to 16 min upon linc00899 knockdown (Fig. 7b, d, f). This delay was smaller compared to a mitotic delay in HeLa cells and is most likely due to the presence of at least 82 chromosomes in HeLa cells that need to be aligned at the metaphase plate, compared to 46 chromosomes present in normal diploid cells. Indeed, the mitotic timing in HeLa cells is at least ~15 min longer than in RPE1, MCF10A and HUVEC cells. Thus linc00899 regulates mitotic progression by controlling TPPP levels in multiple cell lines.
In addition to its mitotic functions, TPPP is crucial for microtubule organisation in the brain. Although TPPP is present in multiple tissues, expression of TPPP is highest in the brain in both mouse48 and human (Supplementary Fig. 12a). In GTEx brain samples, high TPPP expression is accompanied by low levels of linc00899, and in multiple sclerosis patients TPPP and linc00899 expression were negatively correlated (Supplementary Fig. 12b, c). This suggests that the regulatory relationship observed in our study may be physiologically relevant in human brain tissue and neuropathological diseases.
Gain-of-function and rescue studies of linc00899
Linc00089 could regulate TPPP expression in cis (locally) or in trans (distally), as shown for multiple lncRNAs3,5,49. Despite linc00089 and TPPP being located on different chromosomes, a cis-acting mechanism whereby lncRNA interacts with its target site by being tethered to its site of synthesis cannot be excluded. To elucidate the mode of action by which linc00899 regulates TPPP, we compared the effects of ectopic and endogenous overexpression of linc00899 on TPPP levels. Despite an increase in linc00899 expression after its ectopic overexpression using the expression plasmid encoding linc00899 cDNA, no changes in TPPP levels were observed in HeLa and RPE1 cells (Fig. 8a). These results suggest that linc00899 is unlikely to function in trans to regulate TPPP. Indeed, rescue experiments using expression plasmid after RNAi- or LNA-mediated depletion of linc00899 failed to reduce TPPP levels (Fig. 8b). Since linc00899 and TPPP are present on different chromosomes, we tested the effect of linc00899 activation in the context of its normal genomic environment. For that purpose, we employed the CRISPR activation (CRISPRa) system50, which uses catalytically inactive dCas9 fused to transcriptional activator VP64, and gRNAs targeting different regions of the linc00899 promoter. We observed twofold overexpression of linc00899 from its endogenous locus, which led to downregulation of TPPP in the normal diploid RPE1 but not in HeLa cells (Fig. 8c). The lack of TPPP downregulation in HeLa cells may stem from the presence of multiple linc00899 and TPPP alleles; for instance, CRISPRa may not induce overexpression of all (four or more) linc00899 loci. In summary, our data suggest that linc00899 needs to be expressed from its own locus in order to repress TPPP expression.
Linc0889 binds and regulates transcription of TPPP
As shown in Fig. 2, linc00899 is a nuclear- and chromatin-enriched lncRNA, raising the possibility that it could directly regulate transcription of TPPP. To test this, we performed cleavage under targets and release using nuclease (CUT&RUN)51 that allows genome-wide profiling of active and repressive histone modifications as well as transcription factors from low cell numbers. We observed an increase in trimethylation of lysine 4 on histone H3 (H3K4me3), a mark of active transcription, at the promoter of TPPP after RNAi- and LNA-mediated depletion of linc00899 (Fig. 9a). Thus elevated levels of TPPP mRNA in linc00899-depleted cells is likely to arise from increased transcription at the TPPP locus. No significant changes were seen in other active and repressive histone modifications at the TPPP locus (Supplementary Fig. 13).
Based on these findings, we further hypothesised that linc00899 binds to regulatory regions of the TPPP locus. Therefore, we performed capture hybridisation analysis of RNA targets with sequencing (CHART-seq), a method used to identify lncRNA binding sites on chromatin52,53,54,55. We first mapped antisense oligonucleotides whose binding is accessible to linc00899 transcript (Supplementary Fig. 14a) and using the antisense cocktail found approximately tenfold enrichment of linc00899 transcript compared to the control oligonucleotides (Fig. 9b). No enrichment upon pulldown was detected with the negative control transcript 5.8S. After sequencing the enriched genomic DNA using the CHART-seq protocol56, we identified a prominent linc00899-binding site in the intron of TPPP (Fig. 9c; Supplementary Fig. 14b-d); however, we were not able to identify regions with sequence complementarity to the linc00899 transcript (Supplementary Fig. 15). Thus transcriptional upregulation of TPPP is likely to be mediated by linc00899 binding to the TPPP locus through protein interactions. This could occur through a 3D proximity-guided localisation mechanism, which allows low-abundant lncRNAs, such as linc00899, to identify its target genes even on different chromosomes57. Such proximity-guided search has been observed for Firre and CISTR-ACT lncRNAs58,59 and could explain how linc00899, which is encoded on chromosome 22, may bind and regulate TPPP encoded on chromosome 5.
To corroborate that linc00899 act as a transcriptional repressor of TPPP, we performed co-RNA FISH using intronic probes against the premature TPPP and the mature linc00899 transcripts (Fig. 9d). TPPP has eight alleles in the HeLa cell genome (https://cansar.icr.ac.uk/cansar/cell-lines/HELA/copy_number_variation), yet premature TPPP transcripts were detected only in one third of the cells and presented mostly as a single focus. Approximately 3% of cells showed colocalisation between mature linc00899 and premature TPPP transcript. Given that mature linc00899 transcripts can be detected in most cells, this low level of colocalisation is consistent with effective linc00899-mediated suppression of TPPP transcription.
Previous studies have attributed the regulation of the cell cycle primarily to multi-protein networks. Here we performed a high-content imaging screen to identify lncRNAs with functions in cell division. Development of in-house image analysis pipelines coupled with targeted validation of lncRNA-induced phenotypes allowed us to quantify the impact of lncRNA depletion on cell division. Among other lncRNAs, this study identified linc00899 and C1QTNF1-AS1 as lncRNAs involved in the control of mitotic progression.
Our results revealed that linc00899 controls mitotic progression by regulating TPPP, a protein that binds and stabilises the microtubule network at all stages of the cell cycle35,36,37,38,48,60. TPPP also binds to and inhibits histone deacetylase 6, an enzyme responsible for tubulin deacetylation. This binding results in increased tubulin acetylation36, a phenotype also observed upon linc00899 depletion. Fine-tuning TPPP protein levels seems particularly important for mitosis. Indeed, TPPP overexpression in human cells suppresses microtubule growth velocity and normal microtubule dynamics, thereby impeding timely spindle assembly and cell division36. Previous studies have shown that TPPP levels are subject to regulation by microRNAs61 and protein kinases48,60,62; our study now reveals lncRNA-mediated transcriptional control as an additional regulatory layer.
Our mechanistic studies indicate that linc00899 regulates TPPP transcription. In particular, this notion is supported by our findings that (i) linc00899 is a nuclear and chromatin-enriched lncRNA, (ii) linc00899 needs to be expressed from its own locus in order to repress TPPP expression, (iii) H3K4me3 levels increase at the TPPP promoter in linc00899-depleted cells, and (iv) linc00899 binds at the TPPP genomic locus. It is possible that linc00899 contributes to the repressive chromatin landscape at the TPPP locus by altering local chromatin accessibility as observed with other lncRNAs63. The mechanism whereby linc00899 binds to the TPPP genomic locus and represses its transcription remains to be fully defined. Given the limited colocalisation between linc00899 and the premature TPPP transcript, it is more likely that linc00899 uses “proximity-guided search” where transcription site of linc00899 resides in close spatial proximity of TPPP in the nucleus. This would allow linc00899 to act immediately upon its transcription and suppress TPPP expression possibly via interactions with protein complexes, such as chromatin regulators57. It is also possible that the linc00899-mediated regulation of TPPP transcription depends on linc00899 release from the chromatin, with linc00899 target specificity being guided by the pre-established chromosomal proximity, as shown for lncRNA A-ROD64. As we did not observe a strong sequence complementarity between the linc00899 transcript and the TPPP DNA sequence, we excluded the possibility of direct binding of linc00899 to TPPP locus. Instead, our data suggest that the linc00899 function could be mediated through linc00899–protein interactions. Further studies will be required to determine the in vivo linc00899–protein interactome and the relevance of these interactions in TPPP transcriptional regulation and cell division.
TPPP is crucial for microtubule organisation in the brain and for local microtubule nucleation and myelin sheath elongation65. In Drosophila, TPPP mutants (also known as Ringmaker) exhibit defects in axonal extension66. In mammals, it is primarily expressed in oligodendrocytes where it stabilises microtubule networks, and its depletion in progenitors inhibits oligodendrocyte differentiation61. Indeed, TPPP-deficient mice display convulsive seizures and motor coordination deficits65 due to hypomyelination in multiple brain regions, consistent with a defect in myelinating oligodendrocytes67.
In humans, an inverse correlation between TPPP and linc00899 across all tissues is consistent with a regulatory relationship, with the highest expression of TPPP (and lowest expression of linc00899) being observed in the brain. This suggests that linc00899-dependent suppression of TPPP could be used to fine-tune TPPP expression and hence microtubule behaviour in a developmental stage- and tissue-specific manner. Intriguingly, altered TPPP protein levels have been observed in a number of neurodegenerative disorders, including multiple sclerosis and Parkinson’s disease68,69.
In this study, we have comprehensively explored the activity of thousands of lncRNAs in cell cycle regulation and identified an assortment of lncRNAs that are involved in controlling mitotic progression, chromosome segregation and cytokinesis. While our analysis encompassed several cellular features, the imaging data from our screen allows us to extract phenotypes at any stage of cell division upon lncRNA depletion. As interest in the regulatory functions of lncRNAs increases, we anticipate that our data will serve as a powerful resource for prioritising lncRNA candidates for further studies in the RNA and cell cycle fields.
Cell lines and reagents
HeLa and 293FT cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM; Gibco, 41966-029) supplemented with 10% foetal bovine serum (FBS; Thermo Fisher Scientific, 10500064). HeLa cell line was chosen for this study as majority of phenotypic screens, which identified protein-coding genes in cell division, have been performed in HeLa cells (e.g. MitoCheck18). MCF10A (human breast epithelial cell line) were cultured in Mammary Epithelial Cell Growth Medium (Lonza, CC-3151) with supplements and growth factors (Lonza, CC-4136). HUVECs (CC2517, LOT 0000482213) were maintained in Endothelial Cell Growth Medium Lonza (Lonza, CC-3121) with supplements and growth factors (Lonza, CC-4133). RPE1 cells were maintained in Dulbecco’s modified Eagle’s medium F12 Nutrient Mixture (Gibco, 31331-028) supplemented with 10% FBS (Thermo Fisher Scientific, 10500064, LOT 2025814K). All cell lines were obtained from the American Type Culture Collection (ATCC) and were cultured at 37 °C with 5% CO2. HeLa Kyoto (EGFP-α-tubulin/ H2B-mCherry) cells were obtained from ATCC/Jan Ellenberg (EMBL Heidelberg)18 and cultured in DMEM with 10% FBS. All cell lines were verified by short tandem repeat profiling and tested negative for mycoplasma contamination. Paclitaxel (taxol) used in cell culture experiments was dissolved in dimethyl sulfoxide (DMSO; T7402, Sigma) and used at final concentrations of 0.5 or 3 nM. The cells were treated for 1 or 20 h. Final concentration of DMSO in media was 0.05%.
High-content imaging screen: Lincode siRNA library
The Lincode siRNA Library (GE Dharmacon, G-301000) is a collection of siRNA reagents targeting 2231 human lncRNAs (1860 unique human lncRNA genes and 371 lncRNA transcripts associated with protein-coding genes). The design of this library is based on RefSeq version 54 and the siRNAs are arrayed as SMARTpools. The library was purchased at 0.1 nmol in a 96-well format. The library was diluted to a 5 μM stock with 1× siRNA buffer (GE Dharmacon, B-002000-UB-100) and arrayed onto black 384-well PerkinElmer Cell Carrier plates (Perkin Elmer, 6007550) using the Echo Liquid Handler (Labcyte). The black 384-well PerkinElmer Cell Carrier plates were prepared in advance and stored at −80 °C. The final siRNA concentration per well was 20 nM. An siRNA targeting exon 1 of lncRNA GNG12-AS1 (Silencer select, Life Technologies, S59962)70 and SMARTpool siRNAs targeting protein-coding gene CKAP5/Ch-TOG (GE Dharmacon, L-006847-00) were also included on each plate. CKAP5/Ch-TOG was used as a positive control as its depletion leads to mitotic delay and increased mitotic index24. ECT2 SMARTpool siRNAs (GE Dharmacon, L-006450-00-0005) were used as a positive control in the third validation screen as its depletion results in multinucleated cells26.
High-content imaging screen: reverse transfection
To redissolve the siRNA in the black 384-well PerkinElmer Cell Carrier plates (10 plates in total), 5 μl of OptiMEM medium (Thermo Fisher Scientific, 31985047) was added. The plates were centrifuged (1 min, 900 × g) and incubated at room temperature (RT) for 5 min. Lipofectamine RNAimax (Thermo Fisher Scientific, 13778150) was added in OptiMEM medium to a final concentration of 8 μl Lipofectamine to 1 ml OptiMEM medium and incubated at RT for 5 min. Five μl of OptiMEM/Lipofectamine mix was then added to the plates. Plates were centrifuged and incubated at RT for 20 min. In the meantime, HeLa cells were trypsinised and counted using an automated cell counter (Countess, Thermo Fisher Scientific). Cells were centrifuged at 1000 × g for 4 min, the medium was removed and the cells were resuspended in OptiMEM medium to a final concentration of 2000 cells/well. Ten μl of cell suspension was added to the plates, and plates were centrifuged and incubated at 37 °C for 4 h, before adding 10 μl of DMEM+30% FBS+3% P/S (penicillin/streptomycin, P/S) (final concentration 10% FBS, 1% P/S). Plates were centrifuged and incubated at 37 °C for 48 h before fixation. A Multidrop Combi Reagent dispenser (Thermo Fisher Scientific) was used throughout the transfection protocol to ensure even liquid addition.
High-content imaging screen: fixation and immunostaining
For screen A, the plates were fixed by adding an equal volume of pre-warmed (37 °C) 8% formaldehyde (Thermo Fischer Scientific, 28908)/phosphate-buffered saline (PBS) solution to the wells and incubated at 37 °C for 10 min. The cells were permeabilised with pre-warmed PBS/0.2% Triton X-100 (Acros Organics, 327371000) for 15 min at RT. The cells were then blocked in 1% bovine serum albumin (BSA)/PBS for 1 h at RT. To perform the immunostaining, the cells were incubated with primary antibodies against α-tubulin (Dm1α, Sigma, TUB9026, dilution 1:1000), CEP215/CDK5RAP271 (dilution 1:500) and Alexa-Fluor® 568 Phalloidin (Thermo Fisher Scientific, A12380, dilution 1:500) for 2 h at RT. The cells were washed three times in 1× PBS and incubated for 1 h at RT with secondary antibodies Alexa Fluor® 488 (Thermo Fisher Scientific, A21206, dilution 1:1000) and Alexa Fluor® 647 (Thermo Fisher Scientific, A31571, dilution 1:1000). After three washes in 1× PBS, the cells were incubated with 1 µg/ml Hoechst (Sigma, H 33258, diluted in PBS) for 15 min at RT before a final wash in 1× PBS and imaging.
For screen B, the same fixation protocol as described for screen A was used. For permeabilisation, PBS/0.05% sodium dodecyl sulfate was used for 20 min at RT. Blocking was performed as described above. For the immunostaining, cells were incubated with primary antibodies against γ-tubulin (Sigma, GTU88, dilution 1:1000) and phospho-histone H3 serine 10 (PHH3, Millipore, 06-570, dilution 1:2000) for 2 h at RT and washed three times with 1× PBS before incubation with secondary antibodies (Thermo Fisher Scientific, A-31571 and A-21206, both at dilution 1:1000). After three 1× PBS washes, the cells were stained with α-tubulin (Serotec, MCA78G, dilution 1:500) and incubated with secondary antibody (Thermo Fisher Scientific, A-21434, dilution 1:1000). All primary and secondary antibodies were diluted in 1% BSA/PBS. The fixation and staining for both replicates was carried out at the Institute for Cancer Research (ICR, London) using the PerkinElmer Cell:Explorer system coupled to automated liquid handling equipment. Solutions were dispensed using a Multidrop Combi Reagent dispenser (Thermo Fisher Scientific) and aspirated/washed using a Biotek washer with 96 pins. All plates were imaged using the PerkinElmer Opera high-content confocal screening platform with spinning disc. Thirty fields of view per well were captured using a ×20 air objective, numerical aperture (NA) 0.45.
High-content imaging screen: image analysis
All image analysis was performed using custom workflows created with the Columbus software (PerkinElmer). Several output parameters were evaluated from high-content images: mitotic index (number of cells in mitosis), multinucleation index (number of multinucleated cells), number of viable cells, number of chromosome segregation errors (chromatin bridges and lagging chromatids) and number of cells with cytokinetic bridges (Supplementary Fig. 1). These are defined in more detail below.
Mitotic and multinucleation index
Nuclei were first segmented using Hoechst staining (which defines the total cell number). The false positives (e.g. dead cells) were discarded based on the nucleus area, α-tubulin and γ-tubulin/CEP215 staining intensity. Multinucleated non-dividing cells were retained as a separate subpopulation using a two-step detection process: binucleated cells were isolated using size, aspect ratio and roundness parameters of close nucleus pairs. Other multinucleated cells were then identified among remaining cells for which α- or γ-tubulin intensity was low in the perinuclear region. Further identification of mitotic cells/stages was accomplished using filters based on Hoechst for the nucleus shape and size, in combination with high PHH3 (screen B) or high α-tubulin and low CEP215 staining intensity (screen A). Notably, nuclei of cells in anaphase/telophase stage of mitosis were small, had elongated shape and exhibited low Hoechst integrated intensity (low amount of DNA among mitotic cells). The distance between both nuclei of cells in anaphase/telophase stage was the main criteria to discard two daughter non-mitotic cells (maximum of 0.65 and 2.6 µm, respectively). From all these sub-populations, we calculated mitotic and multinucleation index relative to the total number of live cells.
Chromosome segregation errors
We started from the previous identified subpopulation of cells in anaphase/telophase stage. We filtered cells according to α-tubulin staining intensity between nuclei, as cells in anaphase have lower α-tubulin intensity compared to the cells in telophase. This allowed us to identify only the cells in anaphase. To calculate the number of anaphase cells with chromosome segregation errors, the inter-nuclei space was used as the measuring area to calculate the remaining Hoechst signal. This captures both chromatin bridges and lagging chromatids.
Number of viable cells
The total number of viable cells was determined after removal of dead cells and cell debris with anaphase and telophase cells counted as one (despite exhibiting two nuclear segments). The same rule was applied for multinucleated cells.
Number of cytokinetic bridges
Cytokinetic bridges were defined as elongated high-intensity objects split into two parts that are positive for α-tubulin staining. We used prior segmentation of the cytoplasm and the Spot Finder feature to identify bridge half parts and sorted them as doublets by calculating the distance between them. We discarded the false positive candidates based on the shape criteria and γ-tubulin staining. The final number of cytokinetic bridges was divided by the total number of viable cells.
To minimise the variation in the cell density between different wells among all ten 384-well plates, we divided the output numbers by the total number of cells per well (dead cells were not included). Multinucleated cells were considered to be single cells during counting. The ratios were then normalised between screen plates by calculating the average value per plate and finally the grand average of all ten plates, giving a reference mean ratio. Per-well ratios were scaled so that the per-plate average was equal to the reference. Z-scores (z) were calculated as follows for each parameter:
where x represents the ratio for the feature of interest (e.g. mitotic/multinucleation index), μ represents the reference ratio and σ represents the standard deviation of ratios across wells. All the scripts used for the image analysis are available at https://github.com/MarioniLab/LncScreen2018.
High-content imaging screen: third-pass validation screen
The third-pass validation screen was performed in two replicates with four technical replicates using the top 25 candidates from each of the categories (mitotic progression, cytokinesis) using the same antibodies as in screen B. Correlation coefficients between replicate plates in third screen were calculated by Spearman’s rank correlation (mitotic index = 0.967888, viability = 0.93249, multinucleation index = 0.995897, cytokinetic bridges = 0.898324).
Single-molecule RNA FISH
Cells were grown on coverslips in 12-well plates, briefly washed with 1× PBS and fixed with PBS/3.7% formaldehyde at RT for 10 min. Following fixation, cells were washed twice with PBS. The cells were then permeabilised in 70% ethanol for at least 1 h at 4 °C. Stored cells were briefly rehydrated with Wash Buffer (2× SSC, 10% formamide, Biosearch) (Formamide, Thermo Fischer Scientific, BP227-100) before FISH. The Stellaris FISH Probes (linc00899 and C1QTNF1-AS1 exonic probes Q570) were added to the hybridisation buffer (2× SSC, 10% formamide, 10% dextran sulfate, Biosearch) at a final concentration of 250 nM. Hybridisation was carried out in a humidified chamber at 37 °C overnight. The following day, the cells were washed twice with Wash Buffer (Biosearch) at 37 °C for 30 min each. The second wash contained 4,6-diamidino-2-phenylindole for nuclear staining (5 ng/ml, Sigma, D9542). The cells were then briefly washed with 2× SSC and then mounted in Vectashield (Vector Laboratories, H-1000). Images were captured using a Nikon TE-2000 inverted microscope with the NIS-elements software, a Plan Apochromat ×100 objective and an Andor Neo 5.5 sCMOS camera. We acquired 25 optical slices at 0.3-µm intervals. Images were projected in two dimensions using ImageJ and deconvolved with Huygens Professional.
For validation of CHART-sequencing, Stellaris FISH Probes for intronic region of TPPP (Q670) were combined with linc00899 exonic probe (Q570) at a final concentration of 250 nM per probe set. To score whether TPPP (intronic signal) and linc00899 (exonic signal) colocalize, we only considered cells in which both signals were present. The sequences of RNA FISH probes are presented in Supplementary Data 4.
To insert pAS into lncRNAs, pSpCas9(BB)−2A-GFP vector was used (PX458, Addgene, #48138). For CRISPR activation (CRISPRa), pHAGE EF1alpha dCAS-VP64-HA (Addgene, #50918), pU6-sgRNA EF1Alpha-puro-T2A-BFP (Addgene, #60955), second-generation packaging plasmid psPAX2 (Addgene, #12260) and the envelope plasmid pMD2.G (Addgene, #12259) were used. Linc00899 and C1QTNF1-AS1 constructs were synthesised by Labomics. The full sequence of linc00899 was synthesised as CS-LNC233J-T7 (4283 bp, insert was 1610bp based on NR_027036), scrambled linc00899 was CS-LNC236J-T7, full C1QTNF1-AS1 was CS-LNC237JT7 (3638 bp, insert was 970 bp based on NR_040018) and scrambled C1QTNF1-AS1 was CS-LNC238JT7). Sequences of Labomics lncRNA vectors (pUCLOMT) are presented in Supplementary Methods.
RNA isolation, cDNA synthesis and qPCR
RNA (1 µg) was extracted with the RNeasy Kit (QIAGEN, 74106) and treated with DNase I following the manufacturer’s instructions (QIAGEN, 79254). The QuantiTect Reverse Transcription Kit (QIAGEN, 205313) was used for cDNA synthesis including an additional step to eliminate genomic DNA contamination. qPCR was performed on a QuantStudio 6 Flex (Thermo Fischer Scientific) with Fast SYBR Green Master Mix (Life Technologies). Thermocycling parameters were defined as 95 °C for 20 s followed by 40 cycles of 95 °C for 1 s and 60 °C for 20 s. Two reference genes (GAPDH and RPS18) were used to normalise expression levels using the 2−ΔΔCT method. Sequences of qPCR primers are provided in Supplementary Table 1. For linc00899 and C1QTNF1-AS1 primers against exons 2–4 and 1–2, respectively, were used throughout the paper if not indicated otherwise.
siRNA and LNA depletion experiments
HeLa cells were transfected with Lipofectamine RNAiMax reagent (Thermo Fischer Scientific) following the manufacturer’s instructions. All experiments were done 48 h after transfection. The pool of four siRNA sequences (SMARTpool, Thermo Fischer Scientific) and LNA Gapmers (Exiqon) were used at a final concentration of 50 and 25 nM, respectively. For double knockdown experiments, HeLa cells (10,000 cells/well) were plated on 8-well chamber slides (Ibidi, 80826) for time-lapse microscopy imaging or in 6-well for RNA extraction (Corning, 120,000 cells/well). The cells were transfected the next day with either negative control siRNA (Ctl, from Ambion), a SMARTpool of siRNAs targeting linc00899 or TPPP or siRNAs targeting linc00899 in combination with TPPP. The same final concentration of 50 nM was achieved for both single and double knockdown by adding equal amount of control siRNA sequence (Ctl) to the single SMARTpool targeting linc00899 or TPPP separately. siRNA and LNA sequences are listed in Supplementary Tables 2 and 3, respectively.
Western blot analysis
Cells were grown in a six-well plate, trypsinised, pelleted and washed twice with 1× PBS. The pellet was lysed in lysis buffer (50 mM Tris-HCl, pH 8, 125 mM NaCl, 1% NP-40, 2 mM EDTA, 1 mM PMSF [Sigma, 93482-50ML-F] and protease inhibitor cocktail [Roche, 000000011836170001]) and incubated on ice for 25 min. The samples were centrifuged for 3 min at 12,000 × g and 4 °C. Supernatant was collected and protein concentration was determined using the Direct Detect® Spectrometer (Merck Millipore). The proteins (30 µg) were denatured, reduced, and separated with Bolt® 4–12% Bis-Tris Plus Gel (Thermo Fisher Scientific, NW04120BOX) in MOPS buffer (Thermo Fisher Scientific, B0001-02). Precision Plus Protein Standards (161-0373, Bio-Rad) was used as a protein standard. The proteins were then transferred to nitrocellulose membrane and blocked with 5% nonfat milk in TBS-T (50 mM Tris, 150 mM NaCl, 0.1% Tween-20) for 1 h at RT. The membranes were incubated with primary antibodies in 5% milk in TBS-T with the following antibodies: TPPP/p25 (NBP2-34031, Novus, dilution 1:1000), β-tubulin (T019, Sigma, dilution 1:2000), p150 (610473, BD Transduction Laboratories, dilution 1:2000), Cyclin B1 (12231S, Cell signalling, dilution 1:1000), RAI14 (NBP1-94075, Novus, dilution 1:300), DNAAF5 (HPA020243, Atlas Antibodies, dilution 1:250), ITGB1BP1 (HPA071538, Atlas Antibodies, dilution 1:250), and phospho Histone H3 serine 10 (06-570, Millipore, dilution 1:1000). After overnight incubation at 4 °C, the membranes were washed with TBS-T and incubated with horseradish peroxidase secondary antibodies (GE Healthcare Life Sciences, 1:2000), and immunobands were detected with a Pierce ECL Western Blotting Substrate (Thermo Fischer Scientific, 32106). Quantification of immunoblots normalised against appropriate loading controls was done using ImageJ. Uncropped scans of the immunoblots are provided in the Source Data file. The list of all primary and secondary antibodies is provided in Supplementary Table 4.
Time-lapse microscopy imaging
HeLa (10,000 cells/well), HeLa Kyoto (10,000 cells/well), RPE1 (10,000 cells/well), MCF10A (15,000 cells/well) and HUVEC cells (15,000 cells/well) were cultured in 8-well chamber slides (Ibidi) with 200 μl/well of the corresponding medium. Imaging was performed in their corresponding medium. Time-lapse microscopy imaging was performed for all cell lines 48 h after transfection with RNAi or LNA gapmers. Mitotic duration was measured as the time from nuclear envelope breakdown until anaphase onset, based on visual inspection of the images. Cytokinesis was measured from anaphase onset to abscission completion. Live-cell imaging was performed using a Zeiss Axio Observer Z1 microscope equipped with a PL APO 0.95NA ×40 dry objective (Carl Zeiss Microscopy) fitted with a LED light source (Lumencor) and an Orca Flash 4.0 camera (Hamamatsu). Four positions were placed per well and a z-stack was acquired at each position every 10 min (HeLa, HeLa Kyoto) or 5 min (MCF10A, HUVEC, RPE1) for a total duration of 12 h. To detect chromosome segregation errors (chromatin bridges and/or lagging chromatids), HeLa Kyoto cells were imaged every 4 min with only 2 positions/well. Voxel size was 0.325 µm × 0.325 µm × 2.5 µm. Zen software (Zeiss) was used for data collection and analysis. Throughout the experiment, cells were maintained in a microscope stage incubator at 37 °C in a humidified atmosphere of 5% CO2.
Cell cycle synchronisation
HeLa cells were grown to 50% confluency and then synchronised with thymidine for 16 h (2 mM, Sigma, T1895). The cells were washed three times with 1× PBS and then released into thymidine-free medium for 5 h. The cells were released for the indicated timepoints for RNA collection. Treatment of HeLa cells with monastrol (100 µM for 16 h; Tocris, 1305) coupled with the mitotic shake-off was used to isolate mitotic cells.
Copy number evaluation
To calculate the linc00899 and C1QTNF1-AS1 copy number, a standard curve of Ct values was generated by performing qPCR on a dilution series of known concentration of linc00899 or C1QTNF1-AS1 DNA templates (Labomics). cDNA was prepared from RNA (1 µg) extracted from the known number of HeLa cells (500,000 cells). The observed Ct values were fitted on the standard curve and the number of lncRNA molecules per cell was calculated. The final value was multiplied by 2 to account for the fact that cDNA is single stranded and DNA templates used to make the standard curve were double stranded.
RNA library preparation, sequencing and analysis
RNA-seq libraries were prepared from HeLa cells using TruSeq Stranded Total RNA Kit with Ribo-Zero Gold (Illumina, RS-122-2303). We generated four biological replicates for RNAi- and LNA-mediated depletion of linc00899 and C1QTNF1-AS1. Indexed libraries were PCR-amplified and sequenced using 125 bp paired-end reads on an Illumina Hiseq 2500 instrument (CRUK CI Genomics Core Facility). Each library was sequenced to a depth of 20–30 million read pairs. Paired-end reads were aligned to the human genome hg38 with subread and the number of read pairs mapped to the exonic regions of each gene was counted for each library by using the featureCounts72 function in Rsubread v1.30.0 with Ensembl GRCh38 version 91. Only alignments with mapping quality scores >10 and with the first read pair on the reverse strand were considered during counting. Approximately 80% of read pairs contained one read that was successfully mapped to the reference, and 74% of all read pairs in each library were assigned into exonic regions. Any outlier samples with very low depth (resulting from failed library preparation or sequencing) were removed prior to further analysis.
The DE analysis was performed using the limma package v3.36.073. First, lowly expressed genes with average counts <3 were filtered out. Normalisation was performed using the trimmed mean of M-values (TMM) method to remove composition biases. Log-transformed expression values with combined precision/array weights were computed with the voomWithQualityWeights function74. The experimental design was parametrised using an additive model with a group factor, where each group was comprised of all samples from one batch/treatment combination, and an experiment factor, representing samples generated on the same day. Robust empirical Bayes shrinkage75 was performed using the eBayes function to stabilise the variances. Testing for DEGs was performed between pairs of groups using the treat function76 with a log-fold change threshold of 0.5. Here the null hypothesis was that the absolute log2-fold change between groups was ≤0.5. All pairwise contrasts involved groups from the same batch to avoid spurious differences due to batch effects. For each contrast, genes with significant differences in expression between groups were detected at an false discovery rate (FDR) of 5%. To identify DEGs that were consistent across LOF methods, an intersection–union test was performed77 on one-sided P values in each direction, followed by an FDR correction. Coverage tracks for each library were generated using Gviz as previously described.
CHART sequencing and analysis
CHART enrichment and RNase H (NEB, M0297S) mapping was performed as previously described52,56. Briefly, five 150-mm dishes of HeLa cells were used to prepare the CHART extract for each pulldown. In the first sonication step, the samples were sonicated using Covaris S220 (Covaris, 500217) in microTUBEs (Covaris, 520045) in a final volume of 130 µl (Programme conditions: 20% duty cycle, 200 bursts/cycle, Intensity 175, 8 min). The extracts were hybridised with a linc00899 oligonucleotide cocktail (mix of 4 oligos used at final concentration of 25 µM) overnight at RT. MyOne streptavidin beads C1 (Thermo Fischer Scientific, 65001) were used to capture complexes overnight at RT by rotation. Bound material was washed five times and RNase H (NEB) was added for 30 min at RT to elute RNA–chromatin complexes. To increase recovery yield, the remaining beads were saved and the bound material was eluted with Proteinase K (Thermo Fischer Scientific, 25530-049) in 100 µl of XLR buffer for 60 min at 55 °C. The supernatant was then collected and heated for additional 30 min at 65 °C. The RNase H eluate samples were also treated with Proteinase K (Thermo Fischer Scientific, 25530-049) and cross-links were reversed (55 °C for 1 h, followed by 65 °C for 30 min). One fifth of the total sample was used to purify RNA using the miRNeasy Kit (QIAGEN, 217004) and to calculate RNA enrichment, while the rest of the sample was used to purify DNA using Phenol-ChCl3:isoamyl (Thermo Fischer Scientific, 15593-031) extraction and ethanol precipitation. The final CHART DNA was eluted in 12.5 µl of 1× TE buffer (low EDTA, pH 7.4). Ten µl from this reaction was used for sonication using Covaris LE220 (programme 250 bp/10 s) to obtain average fragment size of 200–300 bp. For this, microTUBE-15 beads strips (520159, Covaris) were used in a total volume of 15 µl. After sonication, the DNA was measured by Nanodrop (input, diluted 1:20) and Qubit High Sensitivity DNA Assay (eluates were undiluted). CHART material (5 ng) was used for library preparation using the ThruPLEX DNA-Seq library preparation protocol (Rubicon Genomics, UK). For inputs, six PCR cycles were performed, while for eluates eight PCR cycles were performed owing to the lower quantity of input DNA. Library fragment size was determined using a 2100 Bioanalyzer (Agilent). Libraries were quantified by qPCR (Kapa Biosystems). Pooled libraries were sequenced on a HiSeq4000 (Illumina) according to the manufacturer’s instructions to generate paired-end 150 bp reads (CRUK CI Genomics Core Facility). CHART-seq was performed from five biological replicates using a mix of two sense control oligos for linc00899 as a negative control for the linc00899 pulldown. Reads were aligned to the hg38 build of the human genome using subread in paired-end genomic mode. A differential binding (DB) analysis was performed using csaw to identify lncRNA-binding sites in the pulldown compared to the sense control. Filtered windows were obtained as described for the CUT&RUN data analysis. Normalisation factors were computed by binning read pairs into 5-kbp intervals and applying the TMM method without weighting, to account for composition biases from greater enrichment in the antisense pulldown samples. The filtered windows and normalisation factors were then used in a DB analysis with the quasi-likelihood framework in edgeR. This was performed using an additive design for the generalised linear model fit, containing terms for the batch and the pulldown (five batches in total, sense and antisense pulldowns in each batch). A P value was computed for each window by testing whether the pulldown term was equal to zero, i.e. no difference in coverage between the antisense pulldown and sense control. The above analysis was repeated using window sizes from 150 to 1000 bp to obtain DB results at varying resolutions. These results were consolidated into a single list of DB regions using consolidateWindows as previously described, yielding a combined P value for each region. The combined P values across all regions were then used to compute the empirical FDR (eFDR), defined as the ratio of the number of clusters that exhibited increased coverage in the sense control (i.e. false positives) to the number of clusters with increased coverage in the antisense pulldown (i.e. potentially true discoveries). Putative lncRNA-binding sites were defined at an eFDR of 30%. Coverage tracks for each library were generated using Gviz as previously described. The list of CHART probes and CHART primers is provided in Supplementary Tables 5 and 6, respectively.
CUT&RUN (cleavage under targets and release using nuclease)
Chromatin profiling was performed according to Skene et al.51 with minor modifications. HeLa cells were plated in 30-mm dishes (220,000 cells/dish) and transfected the next day with either negative control siRNA, linc00899 siRNA pool, negative control LNA A or an LNA gapmer targeting linc00899 (LNA1). Two biological replicates were performed per condition. Cells were washed once with PBS, spun down at 600 × g for 3 min in swinging-bucket rotor and washed twice with 1.5 ml Wash buffer (20 mM HEPES-KOH (pH 7.5), 150 mM NaCl, 0.5 mM Spermidine and 1× cOmplete™ EDTA-free protease inhibitor cocktail (Roche)). During the cell washes, concanavalin A-coated magnetic beads (Bangs Laboratories, BP531) (10 µl per condition) were washed twice in 1.5 ml Binding Buffer (20 mM HEPES-KOH (pH 7.5), 10 mM KCl, 1 mM CaCl, 1 mM MnCl2) and resuspended in 10 µl Binding Buffer per condition. Cells were then mixed with beads and rotated for 10 min at RT, and samples were split into aliquots according to the number of antibodies profiled per cell type. We used 80–100,000 cells per chromatin mark. Cells were then collected on magnetic beads and resuspended in 50 µl Antibody Buffer (Wash buffer with 0.05% Digitonin and 2 mM EDTA) containing one of the following antibodies in 1:100 dilution: H3K4me3 (Millipore 05-1339 CMA304, Lot 2780484), H3K27me3 (Cell Signaling #9733 S C36B11, Lot 8), H3K36me3 (Active Motif Cat#61101, Lot 32412003), H3K27ac (Abcam ab4729, Lot GR3211741-1) and Goat Anti-Rabbit IgG H&L (Abcam ab97047, Lot GR254157-8). Cells were incubated with antibodies overnight at 4 °C rotating, and then washed once with 1 ml Digitonin buffer (Wash buffer with 0.05% Digitonin). For the mouse anti-H3K4me3 antibody, samples were incubated with 50 µl of a 1:100 dilution in Digitonin buffer of secondary rabbit anti-mouse antibody (Invitrogen, A27033, Lot RG240909) for 10 min at RT and then washed once with 1 ml Digitonin buffer. Samples were then incubated in 50 µl Digitonin buffer containing 700 ng/ml Protein A-MNase fusion protein (kindly provided by Steven Henikoff) for 10 min at RT followed by two washes with 1 ml Digitonin buffer. Cells were then resuspended in 100 µl Digitonin buffer and cooled down to 4 °C before addition of CaCl2 to a final concentration of 2 mM. Targeted digestion was performed for 30 min on ice until 100 µl of 2× STOP buffer (340 mM NaCl, 20 mM EDTA, 4 mM EGTA, 0.02% Digitonin, 250 mg RNase A, 250 µg Glycogen, 15 pg/ml yeast spike-in DNA (kindly provided by Steven Henikoff)) was added. Cells were then incubated at 37 °C for 10 min to release cleaved chromatin fragments, spun down for 5 min at 16,000 × g at 4 °C and collected on magnet. Supernatant containing the cleaved chromatin fragments were then transferred and cleaned up using the Zymo Clean & Concentrator Kit. Library preparation78 was performed using the ThruPLEX® DNA-Seq Library Preparation Kit (Rubicon Genomics) with a modified library amplification programme: extension and cleavage for 3 min at 72 °C followed by 2 min at 85 °C, denaturation for 2 min at 98 °C followed by four cycles of 20 s at 98 °C, 20 s at 67 °C, and 40 s at 72 °C for the addition of indexes. Amplification was then performed for 12 cycles of 20 s at 98 °C and 15 s at 72 °C (14 cycles were used for the Goat Anti-Rabbit antibody due to the lower yield of input DNA). Double-size selection of libraries was performed using Agencourt AMPure XP beads (Beckman Coulter, A63880) according to the manufacturer’s instructions. Average library size was determined using an Agilent Tapestation DNA1000 High Sensitivity Screentape and quantification was performed using the KAPA Library Quantification Kit. CUT&RUN libraries were sequenced on a HiSeq2500 using a paired-end 125 bp run at the CRUK CI Genomics Core Facility. Reads were aligned to a reference genome containing the hg38 build of the human genome and the R64 build of the yeast genome, using subread v1.6.179 in paired-end genomic mode. A DB analysis was performed using the csaw package v1.14.080 to identify changes in histone mark enrichment in linc00899-depleted cells compared to the negative controls for each LOF method. Coverage was quantified by sliding a window across the genome and counting the number of sequenced fragments overlapping the window in each sample. Windows were filtered to retain only those with average abundances that were fivefold greater than the expected coverage due to background non-specific enrichment. Normalisation factors were computed by applying the TMM method81 without weighting to the filtered windows. The filtered windows and normalisation factors were then used in a DB analysis with the quasi-likelihood framework in the edgeR package v3.22.082. This was performed using an additive design for the generalised linear model fit, containing terms for the batch and the depletion status (two batches in total, depletion and negative control from LNA and RNAi in each batch). A P value was computed for each window by first testing whether for a depletion effect in each LOF method and then taking the larger of the two P values77 across both LOF methods. The above analysis was repeated using window sizes from 150 to 1000 bp to obtain DB results at varying resolutions. To consolidate these results into a single list of DB regions, overlapping windows of all sizes were clustered together based on their genomic locations, using a single-linkage approach in the consolidateWindows function. For each cluster of windows, a combined P value was computed using Simes’ method83. This represents the evidence against the global null hypothesis for each cluster, i.e. that none of the constituent windows are DB. The Benjamini–Hochberg method was used to define putative DB regions at an FDR of 5%. Coverage tracks were generated by computing the number of sequencing fragments per million overlapping each based, using library sizes adjusted according to the TMM normalisation factors for each library. Tracks were visualised using the Gviz package84.
Generation of C1QTNF1-AS1 CRISPR poly(A) site clones
Insertion of the transcriptional termination signal pAS34 into the first exon of C1QTNF1-AS1 was performed using a published CRISPR/CAS9 protocol85. Briefly, the CRISPR pAS guide oligonucleotides were phosphorylated (T4 poly nucleotide kinase; NEB), annealed and ligated (Quick Ligase Kit, NEB) into BbsI (NEB) digested pX458 vector (Addgene, #48138). The oligonucleotides (Sigma-Aldrich, diluted in low TE EDTA buffer at 100 µM) used for the gRNA target sequence are listed in Supplementary Table 7. All inserts were verified with Sanger sequencing. HeLa cells were plated in 6-well plates (200,000 cells/well) and, on the following day, transfected with either 2.5 µg of empty PX458 vector as a control or 2.5 µg of PX458 vector where guide oligonucleotides targeting C1QTNF1-AS1 were cloned together with a symmetric single-stranded oligonucleotide donor86 (ssODN; IDT Inc., 4 µl from 10 µM stock) containing the pAS flanked by homology arms (75 bp) to the target site. Lipofectamine 3000 reagent (Thermo Fisher Scientific, L3000015) was used as transfection reagent according to the manufacturer’s instructions. The sequence of the symmetric ssODNs is as follows (5′ to 3′):
75 bp homology left arm-aataaaagatctttattttcattagatctgtgtgttggttttttgtgtg-75 bp homology right arm
CTCACTGCGGGGCTCGGGAAGGAGGAAAGGAGTGAGCATGTCCTGCTCCTGCATGTCCCTGCTTAAGCTCAGGAC aataaaagatctttattttcattagatctgtgtgttggttttttgtgtg CCCTTCCAGGCCAAGGACCCCAGCATAGACCCCAGGACAGGGCCCCAAGGATCCCTGGCTCATGAGAGCGGCTTGC
The exon 1 of C1QTNF1-AS1 is shown in upper case. The pAS site is in bold and contains BglII restriction sites (AGATCT) that were used for identification of the positive clones. The PAM site (TGG) was abrogated to avoid further cleavage by Cas9.
After 48 h, the GFP-positive cells were sorted using BD FACSAria Ilu (CRUK Flow Cytometry Core Facility) and plated on 96-well plates with DMEM supplemented with 20% FBS. Single-cell clones were expanded and genomic DNA was extracted using Direct PCR Lysis reagent (Viagen, 201-Y; 25 µl/well) with Proteinase K (Thermo Fisher Scientific, 25530-049; 0.4 mg/ml). The plates were incubated for 1 h at 55 °C, followed by 45 min incubation at 85 °C. Two µl of genomic DNA was used for screening by PCR amplification (Phusion® High-Fidelity PCR Master Mix with HF Buffer, NEB, M0531S) of the targeted genomic region. PCR conditions for C1QTNF1-AS1-guide 70 were: 98 °C 30 s, 98 °C 30 s, 70 °C 30 s, 72 °C 30 s (repeat 30×), 72 °C 90 s, 4 °C forever. After PCR, 5 µl was used for BglII digestion (NEB, 2 h at 37 °C) and the products were loaded on a 2% agarose gel to confirm the pAS insertion (Supplementary Fig. 8a). The rest of PCR reaction (15 µl) was also loaded on the gel as a control. Uncropped scan of the gel is provided in the Source Data file. The same genomic PCR product was also ligated into pJET1.2/Blunt and transformed into bacteria (CloneJET; Thermo Fisher Scientific, K1231). To ensure representation by both alleles, plasmids were isolated and sequenced from a minimum of 5–10 bacterial colonies. This method revealed that C1QTNF1-AS1 pAS clones were homozygously targeted clones. Four clones were analysed (clone 95, 136, 153 and 169) by qPCR and live-cell imaging for the mitotic phenotype, along with the wild-type controls (clone 2 and clone 5) that were transfected with an empty vector PX458. We also attempted to perform pAS insertion into exon 1 of linc00899 using two different sgRNAs. However, we failed to obtain homozygous targeted clones, most likely due to the presence of four copies of linc00899 in HeLa cells (https://cansar.icr.ac.uk/cansar/cell-lines/HELA/copy_number_variation/). The list of PCR primers for CRISPR pAS insertion is provided in Supplementary Table 8.
Mapping of 5′ and 3′ ends of linc00899 and C1QTNF1-AS1 by RACE
HeLa total RNA (1 µg) was extracted and 5′ and 3′ RACE was performed using the Smarter RACE Kit (Clontech, 634858). cDNA was synthesised using 5′ and 3′ RACE CDS primers and SMARTer IIA oligo for template switching for 5′ RACE. cDNA ends were then amplified by touchdown PCR. The first PCR (touchdown) used the following conditions: 5 cycles of 94 °C/30 s, 72 °C/3 min; 5 cycles of 94 °C/30 s, 70 °C/30 s, 72 °C 3 min; 25 cycles of 94 °C/30 s, 68 °C/30 s, 72 °C/3 min. For nested PCR, 2 µl of PCR reaction was diluted in 98 µl Tricine-EDTA buffer and used as a template for the second PCR reaction with the following conditions: 25 cycles of 94 °C/30 s, 68 °C/30 s, 72 °C/3 min.
For linc00899, the first PCR used Universal Primer A mixed with linc00899-5R outer 1 = GATTACGCCAAGCTTacatcccggttcccacgaaaagcaacc for the 5′ ends or linc00899-3Routerinner3 = GATTACGCCAAGCTTccagggaggggaaaggagtcggcaat for the 3′ ends. The second (nested) PCR used Nested Universal Primer A and linc00899-5Routerinner1 = GATTACGCCAAGCTTggagcaggcgaagagggagtgagggg for the 5′ ends or linc00899-3R outerinner1 = GATTACGCCAAGCTTggtcacagcctagccaagcccagcca for the 3′ ends.
For C1QTNF1-AS1, the first PCR used Universal Primer A mixed with C1QTNF1-AS1-5-RACE-outer-1 = GATTACGCCAAGCTTccaggcccctaatgatgtcctttga for the 5′ ends or C1QTNF1-AS1-3RACE-outer-1 = GATTACGCCAAGCTTggaggaaaggagtgagcatgtcctg for the 3′ ends. The second nested PCR used Nested Universal Primer A and C1QTNF1-AS1-5RACE-inner-2 = GATTACGCCAAGCTTGTCCTGATCTCCACCTGTCCCAAGC for the 5′ ends or C1QTNF1-AS1-3RACE-inner-2 = GATTACGCCAAGCTTGGAAACTTGGCAGACAGATCCAGCC for the 3′ ends.
For linc00899, nine different 5′ sites and four different 3′ sites were identified. For C1QTNF1-AS1, six different 5′ sites and four different 3′ sites were identified. The fragments were purified after agarose gel electrophoresis with the QiaQuick Gel Extraction Kit (QIAGEN), cloned in pRACE vector as per the kit instructions and transformed into Stellar component cells (Clontech, 636763). The inserts were verified by Sanger sequencing. Uncropped images of RACE results are presented in the Source Data file.
RACE results for linc00899
The most common starting site for linc00899 was CACGTCC, 87 bp upstream from the linc00899 TSS. The most common termination site for linc00899 was acagcaag. Capital italic letters indicate the region upstream of linc00899 TSS (cggccgcccc) based on UCSC.
Based on our sequencing results, linc00899 transcript varied from 1144 to 1532 bp in HeLa cells. We sequenced at least 10 clones per 5′ and 3′ RACE.
RACE results for C1QTNF1-AS1
The most common 5′ site was AGAGAACTA, 54 bp from the C1QTNF1-AS1 TSS. The most common 3′ site was tctggaa. Capital italic letters indicate the region upstream of C1QTNF1-AS1 TSS (gaaggagg) based on UCSC.
Based on our sequencing results, C1QTNF1-AS1 transcript varied from 864 to 952 bp in HeLa cells. We sequenced at least 10 clones per 5′ and 3′ RACE.
Lentiviral overexpression of lncRNAs
To produce lentivirus, HEK293T cells were first transfected with 15 µg of DNA, composed of 9 µg of the lentiviral vector DNA containing the transgene, 4 µg of psPAX.2 and 2 µg of pMD2.G in the final transfection volume of 1.5 ml (including 45 µl of Trans-Lt1 transfection reagent, Mirus) using OptiMEM medium (Thermo Fisher Scientific). Viral supernatant was collected 48 and 72 h post-transfection, spun down at 1800 × g for 5 min at +4 °C and filtered through a 45-µm filter. For overexpression of linc00899 in HeLa and RPE1 cells, linc00899 sequence (Labomics) and negative control vector (scrambled linc00899 sequence) were cloned into pLenti6.3/TO/V5-DEST vector (also known as lincXpress; kindly provided by John Rinn, University of Colorado) using the Gateway cloning strategy70. To overexpress linc00899 from its endogenous locus using CRISPRa, we used pHAGE EF1alpha dCAS9-VP64-HA (Addgene, #50918). Two gRNA sequences targeting different regions of linc00899 (guides 1 and 2) were cloned into pU6-sgRNA EF1Alpha-puro-T2A-BFP (Addgene, #60955). All clones were verified by Sanger sequencing using mU6 forward primers (the mU6 sequence is provided in Supplementary Table 8). HeLa and RPE1 cells were transduced with lentivirus containing dCAS9-VP64 and two gRNA targeting linc00899 or with lentivirus contacting negative gRNA (NC2) in the presence of polybrene (5 µg/ml, Sigma). Twenty-four hours after viral transduction, the medium was exchanged and RNA was collected 48 h later for qPCR analysis. The list of CRISPRa guide sequences and primers to overexpress linc00899 from the lincXpress vector are provided in Supplementary Tables 9 and 10, respectively.
HeLa cells were seeded on coverslips in 6-well plates (120,000/well), transfected the next day with siRNA or LNA gapmers and fixed 48 h post-transfection in ice-cold methanol (Acros Organics, 167830025) for 10 min at −20 °C. The cells were then washed once in 1× PBS and permeabilised with PBS/0.5%Triton-X100 (Acros Organics, 327371000)/0.5%Tween-20 (Promega, H5151) for 5 min at RT followed by blocking in 5% BSA/PBS/0.001% Sodium Azide for 30 min at RT. Cells were incubated with primary antibodies overnight at 4 °C. Antibodies against acetylated α-tubulin (Sigma, T6793, dilution 1:500) and α-tubulin (Serotec, MCA78G, dilution 1:500) or against EB1 (CRUK, dilution 1:300, ref. 87) and α-tubulin (Serotec, MCA78G, dilution 1:500) were used. Cells were washed 3× for 10 min with PBS/0.1%Tween-20 and then incubated with secondary antibodies (Supplementary Table 4) diluted in blocking-buffer for 1 h at RT. After washing again 3× for 10 min with PBS/0.1%Tween-20, cells were stained with 1 µg/ml Hoechst (B2261, Sigma, diluted in PBS) for 10 min at RT. Coverslips were mounted onto glass slides using Prolong Diamond Antifade Mountant (Thermo Fischer Scientific, P36961). To determine the mitotic index, cells were stained with antibodies against PHH3 (Millipore, 06-570, dilution 1:2000) and α-tubulin (Sigma, TUB9026, dilution 1:1000). The mitotic index was calculated by counting the cells in mitosis (positive for PHH3 and α-tubulin) and total number of cells (Hoechst positive). For each sample, at least 100 cells were randomly counted by fluorescence microscopy, and mitotic cells were scored from prophase to anaphase/telophase.
For kinetochore analysis, HeLa cells were grown on coverslips, treated with the indicated siRNAs or LNAs and fixed in PTEMF buffer (0.2% Triton X-100, 0.02 M PIPES (pH 6.8), 0.01 M EGTA, 1 mM MgCl2, 4% formaldehyde) for 10 min at RT. The cells were then washed twice in 1× PBS (5 min), permeabilised in 0.2% Triton X-100 in PBS for 5 min at RT, washed twice in 1× PBS (5 min) and blocked as above. Cells were then incubated with primary antibodies (α-tubulin, Sigma, TUB9026, dilution 1:1000; CREST, Antibodies Inc., 15-234-0001, dilution 1:1000; Mad2, Babco, 924601, dilution 1:100) overnight at 4 °C. CREST/Mad2 images were acquired with 0.3 µm z-slices while 0.5 µm z-slices were used for acetyl α-tubulin/α-tubulin images. The list of all primary and secondary antibodies is provided in Supplementary Table 4.
Image processing and quantification
Imaging of fixed cells was performed on a Leica Sp8 confocal microscope using a 100 ×1.4 numerical aperture Leica oil objective. Images were taken at identical exposure times within each experiment and were imported into ImageJ and Photoshop (CS6, Adobe). Images shown here represent three-dimensional maximum intensity projections. To analyse the ratio of α-tubulin to acetylated α-tubulin, raw integrated intensities were measured (ImageJ) over the total z-stack plane using a circle selection around the mitotic spindle (based on α-tubulin). The measured intensity values were divided by the area of the selection and the background signal was subtracted. Afterwards, the mean of the signal intensity over all z-stacks was calculated, and the ratio of the signal of acetylated-tubulin to α-tubulin was determined. The total EB1 levels were quantified as described above. Inter-KT distance was measured between single kinetochore pairs visible in the same z-stack plane using ImageJ. We calculated the distance between at least seven kinetochore pairs/cell from the single focal plane using the manual line measurement tool.
The cells from a 150-mm dish were used to isolate RNA from cytoplasmic, nucleoplasmic and chromatin fractions by TRIzol extraction70. Turbo DNA-free Kit (Thermo Fischer Scientific, AM1907) was used to remove any traces of DNA. Expression of target genes in each fraction was analysed by qPCR. Data were normalised to the geometric mean of GAPDH and ACTB levels in each cellular compartment. U1 small nuclear RNA was used as a positive control for chromatin fraction.
Coding potential assessment for lncRNAs
The Coding-Potential Calculator88 (CPC; http://cpc.cbi.pku.edu.cn) and Coding Potential Assessment Tool89 (CPAT; http://lilab.research.bcm.edu/cpat/index.php) were used to determine noncoding potential. LncRNAs with CPC scores >1 and CPAT scores >0.364 were predicted to have protein-coding capacity. The PhyloCSF90 score was taken from UCSC (https://github.com/mlin/PhyloCSF/wiki).
The statistical significance of data was determined by two-tailed Student’s t test in all experiments using GraphPad Prism unless indicated otherwise. P values >0.05 were considered statistically not significant.
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
A reporting summary for this article is available as a Supplementary Information file. Sequencing data are available in the ArrayExpress database (http://www.ebi.ac.uk/arrayexpress) with the accession codes E-MTAB-7432 (RNA-seq), E-MTAB-7418 (CHART-seq) and E-MTAB-7419 (CUT&RUN). The imaging data have been submitted to the Image Data Resource (https://idr.openmicroscopy.org) under IDR accession number idr0056. The source data underlying Figs. 2b, d; 3a–c, e–g; 4e–i; 5c, e; 6a, i; 7a–f; 8a–c; and 9b and Supplementary Figs. 2a–d; 3a, b; 4a, b; 5a, b; 6a, c, e, f; 7a, d; 8a, c, d; 9a–c; 10a–e; and 14a, b are provided as a Source Data file. All data are available from the corresponding authors upon reasonable request.
All code used in this analysis is available at https://github.com/MarioniLab/LncScreen2018.
Iyer, M. K. et al. The landscape of long noncoding RNAs in the human transcriptome. Nat. Genet. 47, 199–208 (2015).
Hon, C. C. et al. An atlas of human long non-coding RNAs with accurate 5’ ends. Nature 543, 199–204 (2017).
Fatica, A. & Bozzoni, I. Long non-coding RNAs: new players in cell differentiation and development. Nat. Rev. Genet. 15, 7–21 (2014).
Kitagawa, M., Kitagawa, K., Kotake, Y., Niida, H. & Ohhata, T. Cell cycle regulation by long non-coding RNAs. Cell. Mol. Life Sci. 70, 4785–4794 (2013).
Quinn, J. J. & Chang, H. Y. Unique features of long non-coding RNA biogenesis and function. Nat. Rev. Genet. 17, 47–62 (2016).
Huarte, M. The emerging role of lncRNAs in cancer. Nat. Med. 21, 1253–1261 (2015).
Wapinski, O. & Chang, H. Y. Long noncoding RNAs and human disease. Trends Cell Biol. 21, 354–361 (2011).
Huarte, M. et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142, 409–419 (2010).
Liu, X., Li, D., Zhang, W., Guo, M. & Zhan, Q. Long non-coding RNA gadd7 interacts with TDP-43 and regulates Cdk6 mRNA decay. EMBO J. 31, 4415–4427 (2012).
Kim, J. et al. LncRNA OIP5-AS1/cyrano suppresses GAK expression to control mitosis. Oncotarget 8, 49409–49420 (2017).
Wang, Z. D. et al. Long noncoding RNA lnc-RI is a new regulator of mitosis via targeting miRNA-210-3p to release PLK1 mRNA activity. Sci. Rep. 6, 25385 (2016).
Marchese, F. P. et al. A long noncoding RNA regulates sister chromatid cohesion. Mol. Cell 63, 397–407 (2016).
Rosic, S., Kohler, F. & Erhardt, S. Repetitive centromeric satellite RNA is essential for kinetochore formation and cell division. J. Cell Biol. 207, 335–349 (2014).
Lee, S. et al. Noncoding RNA NORAD regulates genomic stability by sequestering PUMILIO proteins. Cell 164, 69–80 (2016).
Tichon, A., Perry, R. B., Stojic, L. & Ulitsky, I. SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA. Genes Dev. 32, 70–78 (2018).
Marchese, F. P., Raimondi, I. & Huarte, M. The multidimensional mechanisms of long noncoding RNA function. Genome Biol. 18, 206 (2017).
Kittler, R. et al. An endoribonuclease-prepared siRNA screen in human cells identifies genes essential for cell division. Nature 432, 1036–1040 (2004).
Neumann, B. et al. Phenotypic profiling of the human genome by time-lapse microscopy reveals cell division genes. Nature 464, 721–727 (2010).
Kittler, R. et al. Genome-scale RNAi profiling of cell division in human tissue culture cells. Nat. Cell Biol. 9, 1401–1412 (2007).
Schmitz, M. H. et al. Live-cell imaging RNAi screen identifies PP2A-B55alpha and importin-beta1 as key mitotic exit regulators in human cells. Nat. Cell Biol. 12, 886–893 (2010).
Liu, S. J. et al. CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells. Science 355, eaah7111 (2017).
Liu, Y. et al. Genome-wide screening for functional long noncoding RNAs in human cells by Cas9 targeting of splice sites. Nat. Biotechnol. 36, 1203–1210 (2018).
Notzold, L. et al. The long non-coding RNA LINC00152 is essential for cell cycle progression through mitosis in HeLa cells. Sci. Rep. 7, 2265 (2017).
Gergely, F., Draviam, V. M. & Raff, J. W. The ch-TOG/XMAP215 protein is essential for spindle pole organization in human somatic cells. Genes Dev. 17, 336–341 (2003).
Stojic, L. et al. Specificity of RNAi, LNA and CRISPRi as loss-of-function methods in transcriptional analysis. Nucleic Acids Res. 46, 5950–5966 (2018).
Su, K. C., Takaki, T. & Petronczki, M. Targeting of the RhoGEF Ect2 to the equatorial membrane controls cleavage furrow formation during cytokinesis. Dev. Cell 21, 1104–1115 (2011).
Hezroni, H. et al. Principles of long noncoding RNA evolution derived from direct comparison of transcriptomes in 17 species. Cell Rep. 11, 1110–1122 (2015).
Ulitsky, I. Evolution to the rescue: using comparative genomics to understand long non-coding RNAs. Nat. Rev. Genet. 17, 601–614 (2016).
Marin-Bejar, O. et al. The human lncRNA LINC-PINT inhibits tumor cell invasion through a highly conserved sequence element. Genome Biol. 18, 202 (2017).
Quinn, J. J. et al. Revealing long noncoding RNA architecture and functions using domain-specific chromatin isolation by RNA purification. Nat. Biotechnol. 32, 933–940 (2014).
Consortium, G. T. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580–585 (2013).
Wheeler, T. M. et al. Targeting nuclear RNA for in vivo correction of myotonic dystrophy. Nature 488, 111–115 (2012).
Lennox, K. A. & Behlke, M. A. Cellular localization of long non-coding RNAs affects silencing by RNAi more than by antisense oligonucleotides. Nucleic Acids Res. 44, 863–877 (2016).
Levitt, N., Briggs, D., Gil, A. & Proudfoot, N. J. Definition of an efficient synthetic poly(A) site. Genes Dev. 3, 1019–1025 (1989).
Tirian, L. et al. TPPP/p25 promotes tubulin assemblies and blocks mitotic spindle formation. Proc. Natl Acad. Sci. USA 100, 13976–13981 (2003).
Tokesi, N. et al. TPPP/p25 promotes tubulin acetylation by inhibiting histone deacetylase 6. J. Biol. Chem. 285, 17896–17906 (2010).
DeBonis, S., Neumann, E. & Skoufias, D. A. Self protein-protein interactions are involved in TPPP/p25 mediated microtubule bundling. Sci. Rep. 5, 13242 (2015).
Otzen, D. E. et al. p25alpha is flexible but natively folded and binds tubulin with oligomeric stoichiometry. Protein Sci. 14, 1396–1409 (2005).
Webster, D. R. & Borisy, G. G. Microtubules are acetylated in domains that turn over slowly. J. Cell Sci. 92(Pt. 1), 57–65 (1989).
Jordan, M. A. et al. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res. 56, 816–825 (1996).
Derry, W. B., Wilson, L. & Jordan, M. A. Substoichiometric binding of taxol suppresses microtubule dynamics. Biochemistry 34, 2203–2211 (1995).
Jordan, M. A., Toso, R. J., Thrower, D. & Wilson, L. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc. Natl Acad. Sci. USA 90, 9552–9556 (1993).
Akhmanova, A. & Steinmetz, M. O. Control of microtubule organization and dynamics: two ends in the limelight. Nat. Rev. Mol. Cell Biol. 16, 711–726 (2015).
Musacchio, A. & Salmon, E. D. The spindle-assembly checkpoint in space and time. Nat. Rev. Mol. Cell Biol. 8, 379–393 (2007).
Chen, R. H., Waters, J. C., Salmon, E. D. & Murray, A. W. Association of spindle assembly checkpoint component XMAD2 with unattached kinetochores. Science 274, 242–246 (1996).
Li, Y. & Benezra, R. Identification of a human mitotic checkpoint gene: hsMAD2. Science 274, 246–248 (1996).
Barr, A. R. & Gergely, F. MCAK-independent functions of ch-Tog/XMAP215 in microtubule plus-end dynamics. Mol. Cell. Biol. 28, 7199–7211 (2008).
Acevedo, K. et al. The phosphorylation of p25/TPPP by LIM kinase 1 inhibits its ability to assemble microtubules. Exp. Cell Res. 313, 4091–4106 (2007).
Goff, L. A. & Rinn, J. L. Linking RNA biology to lncRNAs. Genome Res. 25, 1456–1465 (2015).
Gilbert, L. A. et al. Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159, 647–661 (2014).
Skene, P. J., Henikoff, J. G. & Henikoff, S. Targeted in situ genome-wide profiling with high efficiency for low cell numbers. Nat. Protoc. 13, 1006–1019 (2018).
Simon, M. D. et al. The genomic binding sites of a noncoding RNA. Proc. Natl Acad. Sci. USA 108, 20497–20502 (2011).
Simon, M. D. et al. High-resolution Xist binding maps reveal two-step spreading during X-chromosome inactivation. Nature 504, 465–469 (2013).
Vance, K. W. et al. The long non-coding RNA Paupar regulates the expression of both local and distal genes. EMBO J. 33, 296–311 (2014).
West, J. A. et al. The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites. Mol. Cell 55, 791–802 (2014).
Vance, K. W. Mapping long noncoding RNA chromatin occupancy using capture hybridization analysis of RNA targets (CHART). Methods Mol. Biol. 1468, 39–50 (2017).
Engreitz, J. M., Ollikainen, N. & Guttman, M. Long non-coding RNAs: spatial amplifiers that control nuclear structure and gene expression. Nat. Rev. Mol. Cell Biol. 17, 756–770 (2016).
Hacisuleyman, E. et al. Topological organization of multichromosomal regions by the long intergenic noncoding RNA Firre. Nat. Struct. Mol. Biol. 21, 198–206 (2014).
Maass, P. G. et al. A misplaced lncRNA causes brachydactyly in humans. J. Clin. Invest. 122, 3990–4002 (2012).
Heng, Y. W. et al. TPPP acts downstream of RhoA-ROCK-LIMK2 to regulate astral microtubule organization and spindle orientation. J. Cell Sci. 125, 1579–1590 (2012).
Lehotzky, A. et al. Tubulin polymerization-promoting protein (TPPP/p25) is critical for oligodendrocyte differentiation. Glia 58, 157–168 (2010).
Hlavanda, E. et al. Phosphorylation blocks the activity of tubulin polymerization-promoting protein (TPPP): identification of sites targeted by different kinases. J. Biol. Chem. 282, 29531–29539 (2007).
Atianand, M. K. et al. A long noncoding RNA lincRNA-EPS acts as a transcriptional brake to restrain inflammation. Cell 165, 1672–1685 (2016).
Ntini, E. et al. Long ncRNA A-ROD activates its target gene DKK1 at its release from chromatin. Nat. Commun. 9, 1636 (2018).
Fu, M. M. et al. The Golgi outpost protein TPPP nucleates microtubules and is critical for myelination. Cell 179, 132.e14–146.e14 (2019).
Mino, R. E. et al. Drosophila Ringmaker regulates microtubule stabilization and axonal extension during embryonic development. J. Cell Sci. 129, 3282–3294 (2016).
Dickinson, M. E. et al. High-throughput discovery of novel developmental phenotypes. Nature 537, 508–514 (2016).
Olah, J. et al. Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein. J. Biol. Chem. 286, 34088–34100 (2011).
Olah, J. & Ovadi, J. Dual life of TPPP/p25 evolved in physiological and pathological conditions. Biochem. Soc. Trans. 42, 1762–1767 (2014).
Stojic, L. et al. Transcriptional silencing of long noncoding RNA GNG12-AS1 uncouples its transcriptional and product-related functions. Nat. Commun. 7, 10406 (2016).
Barr, A. R., Kilmartin, J. V. & Gergely, F. CDK5RAP2 functions in centrosome to spindle pole attachment and DNA damage response. J. Cell Biol. 189, 23–39 (2010).
Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014).
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).
Phipson, B., Lee, S., Majewski, I. J., Alexander, W. S. & Smyth, G. K. Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression. Ann. Appl. Stat. 10, 946–963 (2016).
McCarthy, D. J. & Smyth, G. K. Testing significance relative to a fold-change threshold is a TREAT. Bioinformatics 25, 765–771 (2009).
Berger, R. L. & Hsu, J. C. Bioequivalence trials, intersection-union tests and equivalence confidence sets. Stat. Sci. 11, 283–302 (1996).
Ernst, C., Eling, N., Martinez-Jimenez, C. P., Marioni, J. C. & Odom, D. T. Staged developmental mapping and X chromosome transcriptional dynamics during mouse spermatogenesis. Nat. Commun. 10, 1251 (2019).
Liao, Y., Smyth, G. K. & Shi, W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 41, e108 (2013).
Lun, A. T. & Smyth, G. K. From reads to regions: a Bioconductor workflow to detect differential binding in ChIP-seq data. F1000Res 4, 1080 (2015).
Robinson, M. D. & Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. 11, R25 (2010).
Lun, A. T., Chen, Y. & Smyth, G. K. It’s DE-licious: a recipe for differential expression analyses of RNA-seq experiments using quasi-likelihood methods in edgeR. Methods Mol. Biol. 1418, 391–416 (2016).
Lun, A. T. & Smyth, G. K. De novo detection of differentially bound regions for ChIP-seq data using peaks and windows: controlling error rates correctly. Nucleic Acids Res. 42, e95 (2014).
Hahne, F. & Ivanek, R. Visualizing genomic data using Gviz and Bioconductor. Methods Mol. Biol. 1418, 335–351 (2016).
Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281–2308 (2013).
Richardson, C. D., Ray, G. J., DeWitt, M. A., Curie, G. L. & Corn, J. E. Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA. Nat. Biotechnol. 34, 339–344 (2016).
Zyss, D., Ebrahimi, H. & Gergely, F. Casein kinase I delta controls centrosome positioning during T cell activation. J. Cell Biol. 195, 781–797 (2011).
Kong, L. et al. CPC: assess the protein-coding potential of transcripts using sequence features and support vector machine. Nucleic Acids Res. 35, W345–W349 (2007).
Wang, L. et al. CPAT: Coding-Potential Assessment Tool using an alignment-free logistic regression model. Nucleic Acids Res. 41, e74 (2013).
Lin, M. F., Jungreis, I. & Kellis, M. PhyloCSF: a comparative genomics method to distinguish protein coding and non-coding regions. Bioinformatics 27, i275–i282 (2011).
We thank all the members of Gergely and Odom groups for helpful discussions and Julia Tischer for critical reading of the manuscript. We also thank the Genomics, Microscopy, FACS and Research Instrumentation and Cell Service Core Facilities at the CRUK Cambridge Institute. We thank Keith Vance (University of Bath, UK) and Matthew Simon (Yale, USA) for the help with the CHART-seq protocol, John Rinn (University of Colorado) for the lincXpress vector, Steve Henikoff (Fred Hutchinson Cancer Research Center, USA) for providing the reagents for CUT&RUN and Irene Cantone (University Federico II of Naples) for assistance with the DNA FISH. This work was made possible by funding from Cancer Research UK (C14303/A17197 to D.T.O., F.G., and J.C.M., A24455 to F.G., and A20412 to D.T.O.). We also acknowledge the support of the University of Cambridge, the Wellcome Trust (WT202878; to D.T.O.), European Research Council (615584; to D.T.O.), BBSRC Stratageic LoLa grant (BB/M00354X/1 to C.B. and A.R.B.) and Hutchison Whampoa Limited.
The authors declare no competing interests.
Peer review information Nature Communications thanks the anonymous reviewers for their contribution to the peer review of this work. Peer reviewer reports are available.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Stojic, L., Lun, A.T.L., Mascalchi, P. et al. A high-content RNAi screen reveals multiple roles for long noncoding RNAs in cell division. Nat Commun 11, 1851 (2020). https://doi.org/10.1038/s41467-020-14978-7
This article is cited by
Profilin 1 deficiency drives mitotic defects and reduces genome stability
Communications Biology (2023)
M6A demethylase FTO-mediated downregulation of DACT1 mRNA stability promotes Wnt signaling to facilitate osteosarcoma progression
Designing libraries for pooled CRISPR functional screens of long noncoding RNAs
Mammalian Genome (2022)
Microinjection of antisense oligonucleotides into living mouse testis enables lncRNA function study
Cell & Bioscience (2021)
Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation
Journal of Hematology & Oncology (2020)
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.